GNPX
#5025
Genprex, Inc. - Common Stock
5.9 0 USD
-0.03%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.64%
Monthly Change
+1056.86%
6 month change
+215.51%
Year Change
+215.51%
Previous Close
6.0 6
Open
5.8 8
Low
5.8 8
High
5.9 8
Volume
4
Financials
- Market Capitalization 2.84 M
- Employee 13
- Founded 2009
- CEO N/A
- Website www.genprex.com
- Headquarter Texas, United States
- FIGI BBG00F7T0157
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.1
Price to sales ratio
-9 053.27
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 5006 |  SPRC SciSparc Ltd. - Ordinary Shares | 8.70 USD | -4.29% | +62.62% | +60.81% | +52.10% | 3.18 M USD | ||
| 5019 |  SXTP 60 Degrees Pharmaceuticals, Inc. - Common Stock | 1.18 USD | -5.60% | -21.33% | -28.92% | -11.28% | 3.14 M USD | ||
| 5027 |  XRTX XORTX Therapeutics Inc. - Common Shares | 2.10 USD | +3.96% | +3.96% | -1.87% | +191.67% | 2.92 M USD | ||
| 5029 |  CELZ Creative Medical Technology Holdings, Inc. - Common Stock | 0.70 USD | -7.89% | -14.63% | -48.53% | -74.45% | 2.59 M USD |
Frequently asked questions about Genprex, Inc. - Common Stock
What is the Genprex, Inc. - Common Stock stock price today?
The current price of Genprex, Inc. - Common Stock (GNPX) is 5.9. Over the past 24 hours, the stock has changed by -2.64%. Follow the GNPX chart for real-time price dynamics.
What is the stock ticker of Genprex, Inc. - Common Stock?
Genprex, Inc. - Common Stock trades under the ticker GNPX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Genprex, Inc. - Common Stock stock going up?
GNPX has changed by -24.65% over the last week, +1056.86% over the last month, and +215.51% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Genprex, Inc. - Common Stock?
Genprex, Inc. - Common Stock currently has a market capitalization of 2.84 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Genprex, Inc. - Common Stock earnings last quarter?
Last quarter, Genprex, Inc. - Common Stock reported earnings of -14.08 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Genprex, Inc. - Common Stock revenue for the last quarter?
Genprex, Inc. - Common Stock reported quarterly revenue of 541. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Genprex, Inc. - Common Stock net income for the last quarter?
Genprex, Inc. - Common Stock reported net income of -4.46 M for the last quarter. The previous quarter showed -3.79 M, which means net income changed by -17.72%.
How many employees does Genprex, Inc. - Common Stock have?
As of the latest available data, Genprex, Inc. - Common Stock has 13 employees. Workforce size can provide additional context about the company's scale and operations.
What is Genprex, Inc. - Common Stock EBITDA?
Genprex, Inc. - Common Stock EBITDA is -4.49 M, and its EBITDA margin is -830.62 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Genprex, Inc. - Common Stock stock?
You can buy Genprex, Inc. - Common Stock (GNPX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Genprex, Inc. - Common Stock stock?
Investing in Genprex, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GNPX chart and related analysis on metatrader.com as part of your research.